LDT Foundations: An Overview of FDA's Final Rule on LDTs
The first on-demand webinar is a panel discussion and overview of the FDA's Final Rule on LDTs, including practical resources for your laboratory to implement into practice.
Agenda
Overview of the Ruling | Shannon Bennett, MS, MBA, CMQOE(ASQ)
Q&A Discussion | Michelle Campbell MS, MLS(ASCP)MB, SC; Jonathan Genzen, MD, PhD, MBA; Shannon Bennett, MS, MBA, CMQOE(ASQ)
Method Navigator as a LDT Resource | Tabitha Kern, MS, MLS(ASCP)
Earn 1.0 P.A.C.E. credits for the first webinar.
Learning Objectives
- Describe three main takeaways from the FDA's Final Rule on Laboratory Developed Tests (LDTs).
- Identify two resources that your laboratory can use to prepare for the ruling.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.